OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 69: Line 69:
Carol Beading, “Ion Torrent technology for AML/MDS mutation testing"   
Carol Beading, “Ion Torrent technology for AML/MDS mutation testing"   
|
|
|
|Mac Hall 2201
|--
|--
|10/5/2012
|10/5/2012
|Larry Sherman
|Larry Sherman
|
|
|  
|Mac Hall 2201 
|--
|--
| <font color=red>10/12/2012</font>  
| <font color=red>10/12/2012</font>  
Line 80: Line 80:
|Hematologic Malignancies
|Hematologic Malignancies
|  
|  
|
|Mac Hall 2201 
|--
|--
|10/19/2012
|10/19/2012
Line 86: Line 86:
|
|
|  
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>10/26/2012</font>  
| <font color=red>10/26/2012</font>  
Line 92: Line 92:
|Hematologic Malignancies -  
|Hematologic Malignancies -  
|  
|  
|  
|Mac Hall 2201
|--
|--
|11/2/2012
|11/2/2012
| Jim Korkola
| Jim Korkola
|  
|  
|
|Mac Hall 2201
|--
|--
|11/9/2012
|11/9/2012
| Knight Cancer Institute Retreat
| Knight Cancer Institute Retreat
|  
|  
|
|Mac Hall 2201
|--
|--
| 11/16/2012  
| 11/16/2012  
|Owen McCarty
|Owen McCarty
|  
|  
|  
|Mac Hall 2201
|--
|--
|11/26/2012
|11/26/2012
Line 118: Line 118:
|Hematologic Malignancies  
|Hematologic Malignancies  
|  
|  
|
|Mac Hall 2201
|--
|--
|12/7/2012  
|12/7/2012  
|Thayer Lab   
|Thayer Lab   
|  
|  
|  
|Mac Hall 2201
|--
|--
|<font color=red>12/14/2012</font>  
|<font color=red>12/14/2012</font>  
Line 129: Line 129:
|Hematologic Malignancies -  
|Hematologic Malignancies -  
|  
|  
|  
|Mac Hall 2201
|--
|--
|12/21/2012  
|12/21/2012  
|Charles Keller
|Charles Keller
|  
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>1/4/2013</font>  
| <font color=red>1/4/2013</font>  
|Hematologic Malignancies -   
|Hematologic Malignancies -   
|  
|  
|
|Mac Hall 2201
|--
|--
|1/11/2013
|1/11/2013
Line 145: Line 145:
|
|
|  
|  
|
|Mac Hall 2201
|--
|--
| <font color=red>1/18/2013</font>  
| <font color=red>1/18/2013</font>  
Line 151: Line 151:
|
|
|  
|  
|
|Mac Hall 2201
|--
|--
|1/25/2013
|1/25/2013
|Zhi and Wassana
|Zhi and Wassana
|  
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>2/1/2013</font>  
| <font color=red>2/1/2013</font>  
Line 162: Line 162:
|
|
|  
|  
|
|Mac Hall 2201
|--
|--
|2/8/2013
|2/8/2013
Line 168: Line 168:
|
|
|  
|  
|  
|Mac Hall 2201
|--
|--
| <font color=red>2/15/2013</font>  
| <font color=red>2/15/2013</font>  
|
|
|
|
|
|Mac Hall 2201
|--
|--
|2/22/2013
|2/22/2013
|
|
|  
|  
|
|Mac Hall 2201
|--
|--
| <font color=red>3/1/2013</font>  
| <font color=red>3/1/2013</font>  
Line 184: Line 184:
|
|
|  
|  
|
|Mac Hall 2201
|--
|--
|3/8/2013
|3/8/2013
|  
|  
|  
|  
|
|Mac Hall 2201
|--
|--
| 3/15/2013
| 3/15/2013
Line 195: Line 195:
|  
|  
|  
|  
|
|Mac Hall 2201
|--
|--
|<font color=red>3/22/2013</font>
|<font color=red>3/22/2013</font>
|   
|   
|  
|  
|
|Mac Hall 2201
|--
|--
|3/29/2013  
|3/29/2013  
Line 206: Line 206:
|
|
|
|
|
|Mac Hall 2201
|--
|--
| <font color=red>4/5/2013</font>  
| <font color=red>4/5/2013</font>  
Line 212: Line 212:
|  
|  
|
|
|
|Mac Hall 2201
|--
|--
|4/12/2012
|4/12/2012
Line 218: Line 218:
|
|
|
|
|
|Mac Hall 2201
|--
|--
| <font color=red>4/19/2013</font>  
| <font color=red>4/19/2013</font>  
|
|
|
|
|
|Mac Hall 2201
|--
|--
|4/26/2013
|4/26/2013
Line 229: Line 229:
|
|
|
|
|  
|Mac Hall 2201
|--
|--
| <font color=red>5/3/2013</font>  
| <font color=red>5/3/2013</font>  
|  
|  
|
|
|
|Mac Hall 2201
|--
|--
| 5/10/2013
| 5/10/2013
|
|
|
|
|  
|Mac Hall 2201
|--
|--
|<font color=red>5/17/2013</font>
|<font color=red>5/17/2013</font>
|
|
|
|
|
|Mac Hall 2201
|--
|--
|5/24/2013
|5/24/2013
Line 250: Line 250:
|
|
|
|
|
|Mac Hall 2201
|--
|--
|<font color=red>5/31/2013</font>
|<font color=red>5/31/2013</font>
Line 256: Line 256:
|
|
|  
|  
|
|Mac Hall 2201
|--
|--
|6/7/2013
|6/7/2013
Line 262: Line 262:
|
|
|
|
|
|Mac Hall 2201
|--
|--
|<font color=red>6/14/2013</font>
|<font color=red>6/14/2013</font>
Line 268: Line 268:
|
|
|  
|  
|
|Mac Hall 2201

Revision as of 16:13, 12 September 2012

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       



Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    


Objectives of the OHSU Knight Cancer Biology Research Group Meetings

Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:

  • Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
  • Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:

  • Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
  • Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.

Knight Research Group Activities

Want to join us? All are invited!

To get on the listserve:
go to the following web site:
http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
follow the instructions for subscribing
  • We meet in Mac Hall 2201
Fridays 9:00-10:15 AM - see schedule below
Breakfast provided by the Knight!
  • Organizer: Rosie Sears, email searsrATohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab, MMG

Hoatlin Lab, BMB

Thayer Lab, BMB

Lloyd Lab, CROET

McCullough Lab, CROET

Wong Lab, Dermatology, CDB

Zundel Lab, Radiation Medicine, Cancer Biology

Spindel Lab, Primate Center, NGP, Cancer Biology

Jacques Lab, Biomedical Engineering/Dermatology

  • Add your lab here

Schedule

*Red indicates Translational Cancer Research Group Meetings

Date Presenters Topic Links & Comments Location
9/21/2012 Rebecca Block <blockr@ohsu.edu>
9/28/2012 Guang Fan Hematologic Malignancies - Guang Fan, "Highlights of translational research for Hematologic malignancy in Hemepath division"

Carol Beading, “Ion Torrent technology for AML/MDS mutation testing"

Mac Hall 2201
10/5/2012 Larry Sherman Mac Hall 2201
10/12/2012 Tibor Kovacsovics/William Harv Fleming Hematologic Malignancies Mac Hall 2201
10/19/2012 Wei Huang <huangwe@ohsu.edu> Mac Hall 2201
10/26/2012 Hematologic Malignancies - Mac Hall 2201
11/2/2012 Jim Korkola Mac Hall 2201
11/9/2012 Knight Cancer Institute Retreat Mac Hall 2201
11/16/2012 Owen McCarty Mac Hall 2201
11/26/2012 CANCEL - THANKSGIVING
11/30/2012 Brandon Hayes-Lattin/Rebecca Block Hematologic Malignancies Mac Hall 2201
12/7/2012 Thayer Lab Mac Hall 2201
12/14/2012 Hematologic Malignancies - Mac Hall 2201
12/21/2012 Charles Keller Mac Hall 2201
1/4/2013 Hematologic Malignancies - Mac Hall 2201
1/11/2013 Diane Elliot <elliotd@ohsu.edu> Mac Hall 2201
1/18/2013 Hematologic Malignancies - Mac Hall 2201
1/25/2013 Zhi and Wassana Mac Hall 2201
2/1/2013 Mac Hall 2201
2/8/2013 Mac Hall 2201
2/15/2013 Mac Hall 2201
2/22/2013 Mac Hall 2201
3/1/2013 Mac Hall 2201
3/8/2013 Mac Hall 2201
3/15/2013 Mac Hall 2201
3/22/2013 Mac Hall 2201
3/29/2013 CANCEL - SPRING BREAK Mac Hall 2201
4/5/2013 Mac Hall 2201
4/12/2012 Mac Hall 2201
4/19/2013 Mac Hall 2201
4/26/2013 Mac Hall 2201
5/3/2013 Mac Hall 2201
5/10/2013 Mac Hall 2201
5/17/2013 Mac Hall 2201
5/24/2013 Mac Hall 2201
5/31/2013 Mac Hall 2201
6/7/2013 Mac Hall 2201
6/14/2013 Mac Hall 2201
Retrieved from "https://openwetware.org/mediawiki/index.php?title=OHSU_Knight_Cancer_Institute_Research_Groups:OCI_Research_Group_Meetings&oldid=625688"